DCPH Forecast and Technical Stock Analysis
Buy candidate since 2019-09-04 Gain 0.33% PDF
Deciphera Pharmaceuticals Inc gained 1.01% in the last trading day ( Friday, 13th Sep 2019 ), rising from $36.48 to $36.85 , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 3.47% from a day low at $36.02 to a day high of $37.27. The price has risen in 6 of the last 10 days , but is still down by -1.73% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 99 637 more shares were traded than the day before. In total, 459 065 shares bought and sold for approximately $16.92 million.
- 30 day high of the DCPH stock price was $39.49 and low was $34.04.
- 90 day high was $42.99 and low was $19.88.
- 52 week high for Deciphera Pharmaceuticals Inc - $42.99 and low - $18.55.
Deciphera Pharmaceuticals Inc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 72.02% during the next 3 months and, with 90% probability hold a price between $45.89 and $75.71 at the end of this period.
Only positive signals in the chart today. Deciphera Pharmaceuticals Inc holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $36.27 and $31.80. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday September 10, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 54 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Deciphera Pharmaceuticals Inc finds support from accumulated volume at $36.30.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $1.25 (3.47%) between high and low. For the last week, the stock has had daily average volatility of 5.10%.
Our recommended stop-loss: $35.13 (-4.66%) (This stock has low daily movements and this gives low risk. There is a buy signal from pivot bottom found 3 days ago.)
5.10 %Average volatility
Very Low Low Medium High Very High
|DCPH $36.85 ($0.37 1.01%)|
DCPH is up $0.37 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for DCPH based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the DCPH analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!